亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Selective Neuronal Nitric Oxide Synthase Inhibitors for the Treatment of Human Melanoma

詳細技術說明: Novel compound that inhibits nitric oxide synthase, a key oxidative stress mediator in human melanoma.#diagnostic #cancer #therapeutics

*Abstract: UV radiation exposure, especially sunburn at a young age, is commonly linked to melanoma incidence. As an important environmental carcinogen, UV radiation not only generates reactive oxygen species but also produces a large amount of nitric oxide (NO) in human skin. Upon NO stress by the NO donor DETA, both melanoma proliferation and invasion potential are both significantly stimulated. Northwestern researchers have identified a neural NO synthase (nNOS) that demonstrates an important role in generating NO and mediating NO stress in human melanoma. They have studied the effects on nNOS in vitro cell culture and in vivo human biopsy studies. More interestingly, they discovered that an induction of nNOS was evident with UVB radiation and basic fibroblast growth factor (bFGF) incubation. Conversely, knockdown of nNOS with siRNA efficiently reduced the DETA-induced melanoma proliferation and invasion potential. A novel synthesized nNOS inhibitor, JI-11, has been identified to inhibit nNOS activity. Results show that co-treatment with JI-11 significantly attenuated the alterations induced by UVB radiation and DETA treatments. These studies represent an innovative and promising strategy for melanoma prevention.

*Inventors: Haitao Mark Ji Frank L Meyskens, Jr. Thomas L. Poulos Richard B. Silverman * Fengtian Xue Sun Yang

欲了解更多信息，請點擊這裡